Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

The world-renowned Israeli-Argentine pianist and conductor Daniel Barenboim revealed Thursday he is suffering from ...

The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

“He’s very happy to be coming back and very emotional about this," Sharon told The Sun. “Parkinson’s is a progressive disease ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Ozzy Osbourne shares a heartbreaking update on his Sirius XM radio show about his Parkinson's diagnosis. The rocker tells his fans, 'I can’t walk, but you know what I was thinking over the holidays?

Sharon Osbourne has opened up about the declining health of her husband Ozzy Osbourne amid his ongoing battle with ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...